Smoking Cessation Treatment for Head and Neck Cancer Patients
| Status: | Completed |
|---|---|
| Conditions: | Cancer, Smoking Cessation |
| Therapuetic Areas: | Oncology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/27/2013 |
| Start Date: | July 2009 |
| End Date: | July 2011 |
| Contact: | Benjamin Toll, Ph.D. |
| Email: | benjamin.toll@yale.edu |
| Phone: | 203-974-5767 |
This is a pilot research study examining the use of varenicline (Chantix) and the nicotine
patch. The study is designed to find out whether one of these medications is more effective
for smoking cessation with head and neck cancer patients. The study has three parts: 1) two
intake sessions; 2) an 8-week treatment phase, and 3) a 3-month follow-up.
Inclusion Criteria:
- age 18 or older
- smoking 10 or more cigarettes per day
- diagnosed with and completed an initial course of treatment for any type of head and
neck cancer
- life expectancy of 12 months or more
Exclusion Criteria:
- history of allergic reactions to adhesives
- unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis,
severe alcohol dependence, or dementia
- females of childbearing potential who are pregnant, nursing, or not practicing
effective contraception
We found this trial at
1
site
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
Click here to add this to my saved trials
